Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Activated neu induces rapid tumor progression

C T Guy1, R D Cardiff, W J Muller

  • 1Institute for Molecular Biology and Biotechnology, McMaster University, Hamilton, Ontario, Canada.

The Journal of Biological Chemistry
|March 29, 1996
PubMed
Summary

Activating the neu oncogene in mice rapidly caused mammary tumors. The tissue type influenced whether malignancy occurred, highlighting context in cancer development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: PIK3CA<sup>H1047R</sup>- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling.

Oncogene·2025
Same author

ErbB2-positive mammary tumors can escape PI3K-p110α loss through downregulation of the Pten tumor suppressor.

Oncogene·2017
Same author

Density-dependent mortality in Pinus sylvestris caused by the snow blight pathogen Phacidium infestans.

Oecologia·2017
Same author

A Strategy for the Evaluation of Sensory and Pulmonary Irritation Due to Chemical Emissions from Indoor Sources.

Journal of the Air & Waste Management Association (1995)·2017
Same author

IV pentamidine for Pneumocystis jiroveci pneumonia prophylaxis in pediatric allogeneic stem cell transplant patients.

Bone marrow transplantation·2016
Same author

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.

Oncogene·2016

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The activated neu oncogene's role in mammary epithelial transformation has yielded conflicting results regarding synchronous versus stochastic progression.
  • Understanding the precise mechanisms and dependencies of neu oncogene activation in mammary cancer is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the basis for conflicting observations regarding neu oncogene-induced mammary epithelial transformation.
  • To determine if activated neu transgene expression is sufficient for rapid mammary tumor development in transgenic mice.
  • To assess the role of tissue context in neu-mediated malignant progression.

Main Methods:

  • Generation of additional transgenic mouse strains utilizing the mouse mammary tumor virus (MMTV) promoter/enhancer to control activated neu oncogene expression.
  • Quantitative assessment of activated neu transgene expression using in situ hybridization and ribonuclease protection assays.
  • Histopathological examination of mammary epithelium and other tissues (epididymis) in male and female transgenic mice.

Main Results:

  • Activated neu transgene expression led to rapid conversion of normal mammary epithelium to a malignant phenotype in three independent transgenic mouse strains.
  • In male mice, transgene expression resulted in epididymal epithelial hyperplasia and male infertility, but not malignancy.
  • Expression of activated neu at appropriate levels was sufficient for rapid mammary tumor production.

Conclusions:

  • Tissue context is a critical determinant in malignant progression.
  • Sufficient expression of the activated neu oncogene is adequate for the rapid induction of mammary tumors in transgenic mice.
  • The study resolves conflicting observations by demonstrating the oncogene's potent tumorigenic capacity under specific conditions.

Related Experiment Videos